1)Lipophilic Modifications to Dinucleoside Polyphosphates and Nucleotides that Confer Antagonist Properties at the Platelet P2Y12 Receptor
James G. Douglass*†, Roshni I. Patel‡, Benjamin R. Yerxa†, Sammy R. Shaver†, Paul S. Watson†, Krzysztof Bednarski†, Robert Plourde†, Catherine C. Redick‡, Kurt Brubaker‡, Arthur C. Jones‡ and José L. Boyer‡
Departments of Chemistry and Molecular Pharmacology, Inspire Pharmaceuticals, Inc., 4222 Emperor Boulevard, Suite 200, Durham, North Carolina 27703-8466
J. Med. Chem., 2008, 51 (4), pp 1007–1025
DOI:
- DOI:
http://dx.doi.org/10.1021/jm701348d
Enrica Calleri†∞, Stefania Ceruti‡∞, Gloria Cristalli§∞, Claudia Martini∞, Caterina Temporini†, Chiara Parravicini‡, Rosaria Volpini§, Simona Daniele, Gabriele Caccialanza†, Davide Lecca‡, Catia Lambertucci§, Maria Letizia Trincavelli, Gabriella Marucci§, Irving W. Wainer, Graziella Ranghino×, Piercarlo Fantucci×#, Maria P. Abbracchio‡∞ and Gabriella Massolini
J. Med. Chem., 2010, 53 (9), pp 3489–3501
DOI:
- DOI:
http://dx.doi.org/10.1021/jm901691y
Kenneth A. Jacobson,† Michael F. Jarvis,‡ and Michael Williams
J. Med. Chem., 2002, 45 (19), pp 4057–4093
DOI:
- DOI:
http://dx.doi.org/10.1021/jm020046y